切换至 "中华医学电子期刊资源库"
高级检索
中华危重症医学杂志(电子版)

中华危重症医学杂志(电子版) ›› 2017, Vol. 10 ›› Issue (01) : 28 -33. doi: 10.3877/cma.j.issn.1674-6880.2017.01.006

所属专题： 文献；

论著

脓毒症患者早期血小板功能变化及预后分析
张德厚1, 陈义坤2, 刘大东1,†()   
  1. 1. 212001　江苏镇江，江苏大学附属医院重症医学科
    2. 212001　江苏镇江，江苏大学附属医院急诊科
  • 收稿日期:2016-11-17 出版日期:2017-02-01
  • 通信作者: 刘大东
  • 基金资助:
    江苏省医学会急诊医学分会专项科研课题项目(2015JZKY05)

Changes of platelet function at the early phase of sepsis and its prognosis

Dehou Zhang1, Yikun Chen2, Dadong Liu1,†()   

  1. 1. Department of Internsive Care Unit, the Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China
    2. Department of Emergency Medicine, the Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China
  • Received:2016-11-17 Published:2017-02-01
  • Corresponding author: Dadong Liu
  • About author:
    Corresponding author: Liu Dadong, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

张德厚, 陈义坤, 刘大东. 脓毒症患者早期血小板功能变化及预后分析[J/OL]. 中华危重症医学杂志(电子版), 2017, 10(01): 28-33.

Dehou Zhang, Yikun Chen, Dadong Liu. Changes of platelet function at the early phase of sepsis and its prognosis[J/OL]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2017, 10(01): 28-33.

目的

探讨脓毒症患者早期血小板功能的变化对其预后的影响。

方法

收集2014年1月至2016年4月入住江苏大学附属医院ICU的脓毒症患者41例，按照病情分为脓毒症组（18例）和严重脓毒症组（23例），15例健康志愿者为对照组。比较入选患者和健康志愿者的一般情况、血常规、炎症指标、血小板功能参数，以及脓毒症患者的急性病生理学和长期健康评价（APACHE）Ⅱ评分，入住ICU总天数及28 d生存情况。采用Pearson相关性分析对血小板功能变化与脓毒症患者预后的关系进行研究；采用Logistic回归分析探讨脓毒症患者早期预后的独立危险因素。

结果

与对照组相比，两组脓毒症患者的血小板计数下降显著[（211 ± 36）× 109/L，（133 ± 16）× 109/L，（72 ± 16）× 109/L；P均< 0.05]；而白细胞计数[（6.5 ± 1.6）× 109/L，（13.6 ± 2.2）× 109/L，（22.1 ± 4.3）× 109/L]、白细胞介素6（IL-6）表达水平[（14 ± 5）pg/L，（40 ± 11）pg/L，（71 ± 13）pg/L]、前降钙素原（PCT）[（0.14 ± 0.06）ng/L，（3.87 ± 1.23）ng/L，（7.35 ± 1.41）ng/L]、血小板计数[（211 ± 36）× 109/L，（133 ± 16）× 109/L，（72 ± 16）× 109/L]、血小板黏附率[（26 ± 9）%，（56 ± 10）%，（86 ± 10）%]及聚集率[（42 ± 7）%，（66 ± 8）%，（93 ± 8）%]、P选择素阳性率[（2.2 ± 1.4）%，（15.8 ± 3.1）%，（30.4 ± 7.3）%]均显著增加（P均< 0.05）。相关性分析显示，白细胞计数、IL-6、PCT、APACHEⅡ评分和入住ICU总天数与血小板计数均呈负相关（r = -0.809、-0.834、-0.858、-0.849、-0.816，P均< 0.001），而与平均血小板体积（MPV）（r = 0.375、0.463、0.329、0.342、0.367）、血小板黏附率（r = 0.862、0.792、0.875、0.801、0.771）及聚集率（r = 0.868、0.838、0.911、0.869、0.846）、P选择素阳性率（r = 0.823、0.857、0.845、0.796、0.723）均呈正相关（P均< 0.05）。Logistic回归分析显示，年龄≥ 65岁[OR = 3.792，95%CI（1.033，13.914）]、IL-6 ≥ 200 pg/L [OR = 4.000，95%CI（1.057，15.138）]、PCT ≥ 10 ng/L [OR = 54.000，95%CI（8.038，362.755）]、血小板计数< 50 × 109/L[OR = 6.000，95%CI（1.333，26.999）]、血小板黏附率≥ 60%[OR = 4.643，95%CI（1.241，7.368）]及聚集率≥ 60%[OR = 9.917，95%CI（2.327，42.254）]、应用血管活性药物[OR = 6.000，95%CI（1.514，23.360）]均为脓毒症患者早期预后的独立危险因素（P均< 0.05）。

结论

脓毒症患者早期血小板过度活化促进了其炎症反应、增加了ICU滞留天数、降低了28 d生存情况。

关键词: 脓毒症, 血小板功能, 血小板减少症, 预后
Objective

To investigate the changes of platelet function and prognosis at the early phase of sepsis.

Methods

A total of 41 septic patients in ICU of the Affiliated Hospital of Jiangsu University from January 2014 to April 2016 were divided into the sepsis group (n = 18) and the severe sepsis group (n = 23) according to the severity of their illness. Fifteen healthy volunteers served as the control group. The general condition, hemogram, inflammatory markers, platelet parameters of all enrolled subjects, as well as the acute disease physiology and chronic health evaluation (APACHE) Ⅱ score, the ICU stay time and the 28-day survival status of septic patients were recorded and compared. Pearson correlation analysis was used to study the association between the changes of platelet function and prognosis of septic patients. Logistic regression was used to analyze the independent risk factors of early prognosis for septic patients.

Results

At early phase of sepsis, compared with the control group, the platelet count decreased significantly in the sepsis and severe sepsis groups [(211 ± 36) × 109/L, (133 ± 16) × 109/L, (72 ± 16) × 109/L; all P < 0.05]. However, the levels of WBC [(6.5 ± 1.6) × 109/L, (13.6 ± 2.2) × 109/L, (22.1 ± 4.3) × 109/L], interleukin (IL)-6 [(14 ± 5) pg/L, (40 ± 11) pg/L, (71 ± 13) pg/L] and procalcitonin (PCT) [(0.14 ± 0.06) ng/L, (3.87 ± 1.23) ng/L, (7.35 ± 1.41) ng/L], and the platelet count [(211 ± 36) × 109/L, (133 ± 16) × 109/L, (72 ± 16) × 109/L], the adhesion rate [(26 ± 9)%, (56 ± 10)%, (86 ± 10)%] and the aggregation rate [(42 ± 7)%, (66 ± 8)%, (93 ± 8)%] of platelets, the expression of P-selectin [(2.2 ± 1.4)%, (15.8 ± 3.1)%, (30.4 ± 7.3)%] significantly increased in the sepsis and severe sepsis groups (all P < 0.05). Correlation analysis showed that the platelet count had a negative correlation with WBC, IL-6, PCT, APACHE Ⅱ score, the ICU stay time (r = -0.809, -0.834, -0.858, -0.849, -0.816; all P < 0.001). However, the mean platelet volume (MPV) (r = 0.375, 0.463, 0.329, 0.342, 0.367), the adhesion rate (r = 0.862, 0.792, 0.875, 0.801, 0.771) and the aggregation rate (r = 0.868, 0.838, 0.911, 0.869, 0.846) of platelets, and the expression of P-selectin (r = 0.823, 0.857, 0.845, 0.796, 0.723) had positive correlations with those parameters (all P < 0.05). Logistic regression found that age ≥ 65 years [OR = 3.792, 95%CI (1.033, 13.914)], IL-6 ≥ 200 pg/L [OR = 4.000, 95%CI (1.057, 15.138)], PCT ≥ 10 ng/L [OR = 54.000, 95%CI (8.038, 362.755)], the platelet count < 50 × 109/L [OR = 6.000, 95%CI (1.333, 26.999)], the adhesion rate of platelets ≥ 60% [OR = 4.643, 95%CI (1.241, 7.368)], the aggregation rate of platelets ≥ 60% [OR = 9.917, 95%CI (2.327, 42.254)] and application of vasoactive drugs [OR = 6.000, 95%CI (1.514, 23.360)] were the independent risk factors of early prognosis for septic patients (all P < 0.05).

Conclusion

At the early phase of sepsis, due to the activity of overactive platelets, the inflammatory response was promoted, the ICU stay time was prolonged and the 28-day survival status was shorter.

Key words: Sepsis, Platelet function, Thrombocytopenia, Prognosis
表1 两组脓毒症患者与对照组各实验指标的比较（ ± s）
组别 例数 白细胞计数（× 109/L） IL-6（pg/L） PCT（ng/L） 血小板计数（× 109/L） MPV（fl） 血小板黏附率（%） 血小板聚集率（%） P选择素阳性率（%）
对照组 15 6.5 ± 1.6 14 ± 5 0.14 ± 0.06 211 ± 36 8.8 ± 1.0 26 ± 9 42 ± 7 2.2 ± 1.4
脓毒症组 18 13.6 ± 2.2a 40 ± 11a 3.87 ± 1.23a 133 ± 16a 8.9 ± 0.8 56 ± 10a 66 ± 8a 15.8 ± 3.1a
严重脓毒症组 23 22.1 ± 4.3ab 71 ± 13ab 7.35 ± 1.41ab 72 ± 16ab 9.1 ± 1.3 86 ± 10ab 93 ± 8ab 30.4 ± 7.3ab
F值 ? 114.805 124.681 181.989 168.584 0.253 167.942 210.142 143.319
P值 ? <0.001 <0.001 <0.001 <0.001 0.778 <0.001 <0.001 <0.001
表2 两组脓毒症患者临床特点及实验室指标的比较（例）
组别 例数 年龄≥ 65岁（是/否） 白细胞计数≥ 12 × 109/L（是/否） IL-6 ≥ 200 pg/L（是/否） PCT ≥ 10 ng/L（是/否） 血小板计数<50 × 109/L（是/否） 血小板黏附率≥ 60%（是/否）
死亡组 21 13/8 10/11 12/9 8/13 18/3 15/6
存活组 20 6/14 8/12 5/15 2/18 10/10 7/13
χ2值 ? 4.193 0.241 4.361 4.385 6.034 5.467
P值 ? 0.041 0.623 0.037 0.036 6.034 0.019
组别 例数 血小板聚集率≥ 60%（是/否） P选择素阳性率≥ 10%（是/否） APACHEⅡ评分≥ 20分（是/否） 应用血管活性药物（是/否） 多重病原菌感染（是/否）
死亡组 21 17/4 15/6 10/11 14/7 12/9
存活组 20 6/14 11/9 8/12 5/15 9/11
χ2值 ? 10.798 1.190 0.241 7.150 0.610
P值 ? 0.001 0.275 0.623 0.007 0.437
表3 脓毒症患者早期预后的危险因素分析
危险因素 回归系数 标准误 Wald值 OR值 95%CI P值
年龄≥ 65岁 1.333 0.663 4.037 3.792 1.033 ~ 13.914 0.045
IL-6 ≥ 200 pg/L 1.386 0.679 4.168 4.000 1.057 ~ 15.138 0.041
PCT ≥ 10 ng/L 1.712 0.870 16.868 54.000 8.038 ~ 362.755 < 0.001
血小板计数<50 × 109/L 1.792 0.767 5.452 6.000 1.333 ~ 26.999 0.020
血小板黏附率≥ 60% 1.535 0.673 5.202 4.643 1.241 ~ 17.368 0.023
血小板聚集率≥ 60% 2.294 0.740 9.624 9.917 2.327 ~ 42.254 0.002
应用血管活性药物 1.792 0.694 6.675 6.000 1.514 ~ 23.360 0.010
1
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3)[J]. Jama, 2016, 315 (8): 801-810.
2
Angus DC, van der Poll T. Severe sepsis and septic shock[J]. N Engl J Med, 2013, 369 (9): 840-851.
3
Levy MM, Dellinger RP, Townsend SR, et al. The surviving sepsis campaign: results of an international guideline-based performance improvement program targeting severe sepsis[J]. Intensive Care Med, 2010, 36 (2): 222-231.
4
Liu D, Liang F, Wang X, et al. Suppressive effect of CORM-2 on LPS-induced platelet activation by glycoprotein mediated HS1 phosphorylation interference[J]. PLoS One, 2013, 8 (12): e83112.
5
Stokes KY, Granger DN. Platelets: a critical link between inflammation and microvascular dysfunction[J]. J Physiol, 2012, 590 (5): 1023-1034.
6
Liu DD, Wang X, Qin W, et al. Suppressive effect of exogenous carbon monoxide on endotoxin-stimulated platelet over-activation via the glycoprotein-mediated PI3K-Akt-GSK3beta pathway[J]. Sc Rep, 2016 (6): 23653.
7
庄其宏，史永红，刘群. 凝血异常在社区获得性肺炎病情评估中的应用价值探讨[J]. 中华急诊医学杂志，2016，25(2):200-204.
8
Claushuis TA, van Vught LA, Scicluna BP, et al. Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients[J]. Blood, 2016, 127 (24): 3062-3072.
9
Yaguchi A, Lobo FL, Vincent JL, et al. Platelet function in sepsis[J]. J Thromb Haemost, 2004, 2 (12): 2096-2102.
10
孙建，吴伟东. 脓毒症相关性血小板减少症的危险因素及预后分析[J/CD]. 中华危重症医学杂志（电子版），2014，7(3):177-181.
11
Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference[J]. Crit Care Med, 2003, 31 (4): 1250-1256.
12
赵永祯，李春盛，贾育梅. 降钙素原联合白细胞介素-6对急诊脓毒症患者的预后评估[J]. 中华急诊医学杂志，2015，24(2):160-162.
13
Berthet J, Damien P, Hamzeh-Cognasse H, et al. Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion[J]. Clin Immunol, 2012, 145 (3): 189-200.
14
马建林，马立宁，张银环，等. 血小板膜糖蛋白、血小板聚集率在冠心病合并高血压中的意义[J/CD]. 中华危重症医学杂志（电子版），2013，6(6):10-14.
15
胡才宝，严静，李莉，等. 脓毒症大鼠不同时期炎症因子水平与心功能关系的研究[J/CD]. 中华危重症医学杂志（电子版），2014，7(3):11-15.
16
Crowther MA, Cook DJ, Meade MO, et al. Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors[J]. J Crit Care, 2005, 20 (4): 348-353.
17
Vanderschueren S, De Weerdt A, Malbrain M, et al. Thrombocytopenia and prognosis in intensive care[J]. Crit Care Med, 2000, 28 (6): 1871-1876.
18
Guclu E, Durmaz Y, Karabay O. Effect of severe sepsis on platelet count and their indices[J]. Afr Health Sci, 2013, 13 (2): 333-338.
19
Charoo BA, Iqbal JI, Iqbal Q, et al. Nosocomial sepsis-induced late onset thrombocytopenia in a neonatal tertiary care unit: a prospective study[J]. Hematol Oncol Stem Cell Ther, 2009, 2 (2): 349-353.
20
Mannan MA, Shahidullah M, Noor MK, et al. Utility of C-reactive protein and hematological parameters in the detection of neonatal sepsis[J]. Mymensingh Med J, 2010, 19 (2): 259-263.
21
Guida JD, Kunig AM, Leef KH, et al. Platelet count and sepsis in very low birth weight neonates: is there an organism-specific response?[J]. Pediatrics, 2003, 111 (6 Pt 1): 1411-1415.
22
Catal F, Tayman C, Tonbul A, et al. Mean platelet volume (MPV) may simply predict the severity of sepsis in preterm infants[J]. Clin Lab, 2014, 60 (7): 1193-1200.
23
Kim CH, Kim SJ, Lee MJ, et al. An increase in mean platelet volume from baseline is associated with mortality in patients with severe sepsis or septic shock[J]. PLoS One, 2015, 10 (3): e0119437.
24
高洁，靳英辉，吴荷宁，等. 脓毒症相关弥漫性血管内凝血患者使用重组人可溶性血栓调节蛋白疗效的Meta分析[J/CD]. 中华危重症医学杂志（电子版），2015，8(6):361-365.
25
Levi M, van der Poll T. Inflammation and coagulation[J]. Crit Care Med, 2010, 38 (2 Suppl): S26-34.
26
Secor D, Li F, Ellis CG, et al. Impaired microvascular perfusion in sepsis requires activated coagulation and P-selectin-mediated platelet adhesion in capillaries[J]. Intensive Care Med, 2010, 36 (11): 1928-1934.
[1] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[2] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[3] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[4] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[5] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[6] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[7] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[8] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[9] 陈樽, 王平, 金华, 周美玲, 李青青, 黄永刚. 肌肉减少症预测结直肠癌术后切口疝发生的应用研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 639-644.
[10] 刘郁, 段绍斌, 丁志翔, 史志涛. miR-34a-5p 在结肠癌患者的表达及其与临床特征及预后的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 485-490.
[11] 陈倩倩, 袁晨, 刘基, 尹婷婷. 多层螺旋CT 参数、癌胚抗原、错配修复基因及病理指标对结直肠癌预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 507-511.
[12] 曾明芬, 王艳. 急性胰腺炎合并脂肪肝患者CT 与彩色多普勒超声诊断参数与其病情和预后的关联性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 531-535.
[13] 沈炎, 张俊峰, 唐春芳. 预后营养指数结合血清降钙素原、胱抑素C及视黄醇结合蛋白对急性胰腺炎并发急性肾损伤的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 536-540.
[14] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
[15] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号